glp 1 with ulcerative colitis and GLP-1 medications are a major focus for scientists right now., Here’s what’s happening: between 2024 and 2025, at least six studies have been published in respected journals Frontiers | GLP-1 receptor agonists

Review the detailed semaglutide versus tirzepatide comparison to understand the practical differences

GLP-1 Up works with your body, not against it

While the first GLP-1 was approved by the FDA more than 20 years ago, to treat Type 2 diabetes, the use of these drugs took off in 2021 when Novo Nordisk received approval for a semaglutide drug to treat obesity, with the brand name Wegovy

Insurance companies have increasingly cut back on coverage for GLP-1 drugs, such as Wegovy and Ozempic

But a small number of people may experience eye-related side effects, especially if they already have certain eye conditions

What the trial data actually showed Evolus ran a U.S